STAT+: At ASCO Day 3, AstraZeneca dominates, Takeda reveals experimental drug data, Eli Lilly serves salad
Let's talk about what happened today at ASCO, the world's biggest cancer meeting.
This is the web version of STAT’s special newsletter from the annual meeting of the American Society of Oncology. For more updates on the latest in cancer news, sign up for our Cancer Briefing newsletter here.
We’re going to get to today’s new data in a minute, but first let’s deal with a less serious matter: the marketing of pharmaceutical products via the food attendees need to consume at giant medical meetings.
Genentech has been a longtime leader on this front. At cancer meetings, the cookies the company hands out at its booths are almost as famous as its drugs. An innovation this year: Genentech s’mores, with Genentech-branded marshmallows toasted with a blowtorch. Warning: These things are messy. Other innovations in booth food: Novartis had charcuterie (guys, you know preserved meat is carcinogenic, right?) and Eli Lilly had a salad bar. The lettuce did not have a Lilly logo.
